These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16422968)

  • 1. Health care cost implications of sildenafil citrate.
    Miner M
    J Sex Med; 2004 Sep; 1(2):141-9. PubMed ID: 16422968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tough choices: the cost-effectiveness of sildenafil.
    McGarvey MR
    Ann Intern Med; 2000 Jun; 132(12):994-5. PubMed ID: 10858184
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of sildenafil.
    Smith KJ; Roberts MS
    Ann Intern Med; 2000 Jun; 132(12):933-7. PubMed ID: 10858175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and cost of sildenafil in a large managed care organization with a quantity limit on sildenafil.
    Cooke CE; Wong W; Lee H
    J Manag Care Pharm; 2005 Oct; 11(8):674-80. PubMed ID: 16194131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicalised erections on demand?
    Black D
    J Med Ethics; 1999 Feb; 25(1):5-7. PubMed ID: 10070631
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review assessing the economic impact of sildenafil citrate (Viagra) in the treatment of erectile dysfunction.
    Martin AL; Huelin R; Wilson D; Foster TS; Mould JF
    J Sex Med; 2013 May; 10(5):1389-400. PubMed ID: 23347555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic aspects of medical erectile dysfunction therapies.
    Anastasiadis AG; Ghafar MA; Burchardt M; Shabsigh R
    Expert Opin Pharmacother; 2002 Mar; 3(3):257-63. PubMed ID: 11866676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economics of Viagra.
    Keith A
    Health Aff (Millwood); 2000; 19(2):147-57. PubMed ID: 10718028
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethical questions posed by the medical treatment of erectile dysfunction].
    Jardin A
    Rev Prat; 2001 Feb; 51(4):353-4. PubMed ID: 11355596
    [No Abstract]   [Full Text] [Related]  

  • 10. Socioeconomic considerations in erectile dysfunction treatment.
    Shabsigh R
    Urol Clin North Am; 2001 May; 28(2):417-22. PubMed ID: 11402592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost utility analysis of sildenafil compared with papaverine-phentolamine injections.
    Stolk EA; Busschbach JJ; Caffa M; Meuleman EJ; Rutten FF
    BMJ; 2000 Apr; 320(7243):1165-8. PubMed ID: 10784537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing a Niagara of viagra.
    Harv Health Lett; 2003 Feb; 28(4):7. PubMed ID: 12604455
    [No Abstract]   [Full Text] [Related]  

  • 13. Sildenafil citrate (Viagra): oral medication for treating erectile dysfunction.
    Kosier JH; Newton M; Smith D
    Urol Nurs; 1999 Jun; 19(2):158-60. PubMed ID: 10633767
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical monograph for drug formulary review: erectile dysfunction agents.
    Campbell HE
    J Manag Care Pharm; 2005 Mar; 11(2):151-71. PubMed ID: 15766322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use.
    Nurnberg HG; Duttagupta S
    Am J Ther; 2004; 11(1):9-12. PubMed ID: 14704590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of sildenafil calls for political discussion.
    Stolk E; Busschbach J
    BMJ; 2000 Aug 19-26; 321(7259):510. PubMed ID: 11012253
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate.
    Seidman SN; Roose SP; Menza MA; Shabsigh R; Rosen RC
    Am J Psychiatry; 2001 Oct; 158(10):1623-30. PubMed ID: 11578994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.
    Tan HL
    Pharmacoeconomics; 2000 Jan; 17(1):77-107. PubMed ID: 10747767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing of sildenafil by national insurance program physicians. What basic sexual medicine qualification is required?].
    Vauth R; Berner M; Wetterauer U; Berger M
    Fortschr Med Orig; 2001 Jan; 118(4):173-9. PubMed ID: 11217683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.
    McMahon CG; Samali R; Johnson H
    J Urol; 2000 Oct; 164(4):1192-6. PubMed ID: 10992364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.